西班牙脏病患者注册:2022年报告和进化分析
Borja Quiroga1, Beatriz Mahíllo2, Auxiliadora Mazuecos3
1Servicio de Nefrología, Hospital Universitario de la Princesa, Madrid, Comunidad de Madrid, Spain; Coordinador de Registros de la Sociedad Española de Nefrología (S.E.N.); RICORS 2040.
Nefrologia
|April 2, 2025
概括
在西班牙,替代疗法 (RRT) 的发生率和流行率正在上升,尽管最近的稳定. 移植率很高,但需要采取进一步措施来优化护理和解决慢性病 (CKD).
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 慢性病 (CKD) 是西班牙日益严重的公共卫生问题,预计到2100年将成为第二大死亡原因.
- 西班牙病登记处 (REER) 对于监测西班牙替代疗法 (RRT) 至关重要.
研究的目的:
- 分析2013年至2022年在西班牙需要RRT的患者的发病率,流行率和死亡率趋势.
- 确定导致RRT的CKD的主要原因,并评估区域差异.
主要方法:
- 从西班牙自治区和国家移植组织收集的数据.
- 使用西班牙人口数据计算RRT发病率,流行率和死亡率.
- 对2013-2022年期间趋势的分析.
主要成果:
- 从2013年到2019年,RRT发病率增加了21%,在2022年稳定在每百万人口 (pmp) 的152.2例. 血液透析 (HD) 仍然占主导地位 (77.8%).
- 糖尿病是CKD的主要原因 (21.8%). 在RRT发病率存在显著的区域差异,男性的发病率更高.
- 在2022年,RRT患病率达到1391.1 pmp,这是由于移植人口的增加所致. 在全球范围内,西班牙在移植方面处于领先地位 (2022年为71.7 pmp).
结论:
- 在西班牙,RRT的发病率和流行率继续增加,尽管最近的稳定性得到了注意到.
- 西班牙证明了世界领先的移植活动.
- 需要协调和优化脏医疗保健策略来管理不断增加的CKD负担.
相关概念视频
Renal Drug Excretion: Overview
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules out...
Renal Drug Excretion: Tubular Reabsorption
Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...
Renal Drug Excretion: Tubular Secretion
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Renal Drug Clearance: Overview
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...


